Medcamp S.A. (WSE:MDP)
Poland
· Delayed Price · Currency is PLN 0.840
+0.060 (7.69%)
At close: Apr 28, 2026
Medcamp Statistics
Total Valuation
Medcamp has a market cap or net worth of PLN 21.97 million. The enterprise value is 21.23 million.
| Market Cap | 21.97M |
| Enterprise Value | 21.23M |
Important Dates
The next confirmed earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medcamp has 26.15 million shares outstanding.
| Current Share Class | 26.15M |
| Shares Outstanding | 26.15M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.95% |
| Owned by Institutions (%) | n/a |
| Float | 15.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 42.63 |
| P/TBV Ratio | 42.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.22 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.55 |
| Quick Ratio | 2.53 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.19 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -2,219.53% |
| Return on Capital Employed (ROCE) | -46.50% |
| Weighted Average Cost of Capital (WACC) | 7.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Medcamp has paid 181,784 in taxes.
| Income Tax | 181,784 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.30% in the last 52 weeks. The beta is 0.55, so Medcamp's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -9.30% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 0.81 |
| Relative Strength Index (RSI) | 64.96 |
| Average Volume (20 Days) | 6,033 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -330 |
| Operating Income | -239,632 |
| Pretax Income | -3.23M |
| Net Income | -3.41M |
| EBITDA | n/a |
| EBIT | -239,632 |
| Earnings Per Share (EPS) | -0.13 |
Balance Sheet
The company has 801,682 in cash and 66,601 in debt, giving a net cash position of 735,081 or 0.03 per share.
| Cash & Cash Equivalents | 801,682 |
| Total Debt | 66,601 |
| Net Cash | 735,081 |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 515,318 |
| Book Value Per Share | 0.02 |
| Working Capital | 515,319 |
Cash Flow
| Operating Cash Flow | -321,504 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 1,660 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Medcamp does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -15.53% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |